These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. West African Network for Clinical Trials of Antimalarial Drugs (WANECAM) Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Pyronaridine-Artesunate plus Single-Dose Primaquine for the Treatment of Malaria in Western Cambodia. Leang R; Khim N; Chea H; Huy R; Mairet-Khedim M; Mey Bouth D; Dorina Bustos M; Ringwald P; Witkowski B Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358594 [TBL] [Abstract][Full Text] [Related]
9. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria. Pryce J; Taylor M; Fox T; Hine P Cochrane Database Syst Rev; 2022 Jun; 6(6):CD006404. PubMed ID: 35726133 [TBL] [Abstract][Full Text] [Related]
10. Pyronaridine-artesunate Efficacy and Safety in Uncomplicated Plasmodium falciparum Malaria in Areas of Artemisinin-resistant Falciparum in Viet Nam (2017-2018). Quang Bui P; Hong Huynh Q; Thanh Tran D; Thanh Le D; Quang Nguyen T; Van Truong H; Khim N; Witkowski B; Cong Tran D; Bustos MD; Ringwald P; Thi Ta T Clin Infect Dis; 2020 May; 70(10):2187-2195. PubMed ID: 31251812 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L; Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Pyronaridine-Artesunate for the Treatment of Uncomplicated Han KT; Lin K; Han ZY; Myint MK; Aye KH; Thi A; Thapa B; Bustos MD; Borghini-Fuhrer I; Ringwald P; Duparc S Am J Trop Med Hyg; 2020 Sep; 103(3):1088-1093. PubMed ID: 32524960 [TBL] [Abstract][Full Text] [Related]
13. Clinical and In Vitro Resistance of Plasmodium falciparum to Artesunate-Amodiaquine in Cambodia. Mairet-Khedim M; Leang R; Marmai C; Khim N; Kim S; Ke S; Kauy C; Kloeung N; Eam R; Chy S; Izac B; Mey Bouth D; Dorina Bustos M; Ringwald P; Ariey F; Witkowski B Clin Infect Dis; 2021 Aug; 73(3):406-413. PubMed ID: 32459308 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials. Duparc S; Borghini-Fuhrer I; Craft CJ; Arbe-Barnes S; Miller RM; Shin CS; Fleckenstein L Malar J; 2013 Feb; 12():70. PubMed ID: 23433102 [TBL] [Abstract][Full Text] [Related]
15. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial. Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P Malar J; 2018 May; 17(1):199. PubMed ID: 29764419 [TBL] [Abstract][Full Text] [Related]
16. Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study. Tona Lutete G; Mombo-Ngoma G; Assi SB; Bigoga JD; Koukouikila-Koussounda F; Ntamabyaliro NY; Ntoumi F; Agnandji ST; Groger M; Shin J; Borghini-Fuhrer I; Arbe-Barnes S; Allen SJ; Kremsner PG; Miller R; Duparc S; Ramharter M; PLoS Med; 2021 Jun; 18(6):e1003669. PubMed ID: 34129601 [TBL] [Abstract][Full Text] [Related]
17. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Amaratunga C; Sreng S; Suon S; Phelps ES; Stepniewska K; Lim P; Zhou C; Mao S; Anderson JM; Lindegardh N; Jiang H; Song J; Su XZ; White NJ; Dondorp AM; Anderson TJ; Fay MP; Mu J; Duong S; Fairhurst RM Lancet Infect Dis; 2012 Nov; 12(11):851-8. PubMed ID: 22940027 [TBL] [Abstract][Full Text] [Related]
18. Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial. Kayentao K; Doumbo OK; Pénali LK; Offianan AT; Bhatt KM; Kimani J; Tshefu AK; Kokolomami JH; Ramharter M; de Salazar PM; Tiono AB; Ouédraogo A; Bustos MD; Quicho F; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L Malar J; 2012 Oct; 11():364. PubMed ID: 23113947 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial. Sagara I; Beavogui AH; Zongo I; Soulama I; Borghini-Fuhrer I; Fofana B; Camara D; Somé AF; Coulibaly AS; Traore OB; Dara N; Kabore MJ; Thera I; Compaore YD; Sylla MM; Nikiema F; Diallo MS; Dicko A; Gil JP; Borrmann S; Duparc S; Miller RM; Doumbo OK; Shin J; Bjorkman A; Ouedraogo JB; Sirima SB; Djimdé AA Lancet Infect Dis; 2016 Feb; 16(2):189-98. PubMed ID: 26601738 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of pyronaridine-artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study. Ramharter M; Djimde AA; Borghini-Fuhrer I; Miller R; Shin J; Aspinall A; Richardson N; Wibberg M; Fleckenstein L; Arbe-Barnes S; Duparc S Malar J; 2024 Feb; 23(1):61. PubMed ID: 38418982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]